Venrock Healthcare Capital Partners III, L.P.

KALV

Venrock Healthcare Capital Partners III, L.P. serves as 10 percent owner at KalVista Pharmaceuticals, Inc. (KALV). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

14 trades

$20.84M

Total Sells

1 trades

$3.69M

Net Position

Net Buyer

$17.15M

Companies Traded

KALV, ORKA

Active Period

Dec 2023 – Mar 2026

15 total trades

Most Recent

Sell KALV

Mar 27, 2026 · $3.69M

Venrock Healthcare Capital Partners III, L.P.'s Insider Trading at KalVista Pharmaceuticals, Inc. (KALV)

Buys

13 · $19.44M

Sells

1 · $3.69M

Total Shares Bought

1,612,229

Total Shares Sold

214,631

KALV Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Mar 27, 2026	Sell	214,631	$17.20	$3.69M	5,129,500
Apr 11, 2025	Buy	25,000	$9.42	$235.5K	5,303,985
Feb 14, 2025	Buy	161,700	$9.27	$1.50M	5,278,985
Feb 11, 2025	Buy	104,489	$9.26	$967.1K	5,117,285
Feb 3, 2025	Buy	70,023	$8.88	$621.6K	5,012,796
Feb 8, 2024	Buy	86,048	$14.62	$1.26M	4,824,731
Feb 1, 2024	Buy	88,099	$14.47	$1.27M	4,738,683
Jan 29, 2024	Buy	91,804	$14.05	$1.29M	4,650,584
Jan 24, 2024	Buy	99,129	$12.53	$1.24M	4,558,780
Jan 19, 2024	Buy	143,605	$12.55	$1.80M	4,459,651
Jan 16, 2024	Buy	26,246	$12.72	$333.8K	4,316,046
Jan 10, 2024	Buy	137,700	$12.54	$1.73M	4,289,800
Jan 5, 2024	Buy	59,369	$12.14	$720.5K	4,152,100
Dec 29, 2023	Buy	519,017	$12.46	$6.47M	4,092,731